X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Pfizer - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs PFIZER - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD PFIZER WYETH LTD/
PFIZER
 
P/E (TTM) x 27.7 24.2 114.4% View Chart
P/BV x 5.3 3.9 138.9% View Chart
Dividend Yield % 1.3 0.8 151.5%  

Financials

 WYETH LTD   PFIZER
EQUITY SHARE DATA
    WYETH LTD
Mar-13
PFIZER
Mar-16
WYETH LTD/
PFIZER
5-Yr Chart
Click to enlarge
High Rs1,0442,724 38.3%   
Low Rs8181,611 50.8%   
Sales per share (Unadj.) Rs298.6440.9 67.7%  
Earnings per share (Unadj.) Rs57.248.7 117.6%  
Cash flow per share (Unadj.) Rs58.475.8 77.1%  
Dividends per share (Unadj.) Rs17.0015.00 113.3%  
Dividend yield (eoy) %1.80.7 263.8%  
Book value per share (Unadj.) Rs249.5462.9 53.9%  
Shares outstanding (eoy) m22.7245.75 49.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.14.9 63.4%   
Avg P/E ratio x16.344.5 36.5%  
P/CF ratio (eoy) x15.928.6 55.7%  
Price / Book Value ratio x3.74.7 79.7%  
Dividend payout %29.730.8 96.4%   
Avg Mkt Cap Rs m21,15799,163 21.3%   
No. of employees `0000.52.9 17.0%   
Total wages/salary Rs m4002,758 14.5%   
Avg. sales/employee Rs Th13,787.46,981.7 197.5%   
Avg. wages/employee Rs Th813.0954.5 85.2%   
Avg. net profit/employee Rs Th2,643.3771.1 342.8%   
INCOME DATA
Net Sales Rs m6,78320,170 33.6%  
Other income Rs m353857 41.1%   
Total revenues Rs m7,13621,028 33.9%   
Gross profit Rs m1,6174,310 37.5%  
Depreciation Rs m271,239 2.1%   
Interest Rs m65 105.8%   
Profit before tax Rs m1,9383,923 49.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-599 -5.2%   
Tax Rs m6321,794 35.2%   
Profit after tax Rs m1,3012,228 58.4%  
Gross profit margin %23.821.4 111.6%  
Effective tax rate %32.645.7 71.3%   
Net profit margin %19.211.0 173.6%  
BALANCE SHEET DATA
Current assets Rs m6,98416,299 42.8%   
Current liabilities Rs m2,0567,594 27.1%   
Net working cap to sales %72.643.2 168.3%  
Current ratio x3.42.1 158.3%  
Inventory Days Days9965 152.1%  
Debtors Days Days2426 93.0%  
Net fixed assets Rs m2448,622 2.8%   
Share capital Rs m227458 49.7%   
"Free" reserves Rs m5,44120,722 26.3%   
Net worth Rs m5,66821,180 26.8%   
Long term debt Rs m2525 100.0%   
Total assets Rs m7,90129,137 27.1%  
Interest coverage x353.3755.5 46.8%   
Debt to equity ratio x00 373.7%  
Sales to assets ratio x0.90.7 124.0%   
Return on assets %16.57.7 215.7%  
Return on equity %22.910.5 218.1%  
Return on capital %34.019.0 179.3%  
Exports to sales %0.20.1 366.7%   
Imports to sales %36.317.5 207.9%   
Exports (fob) Rs m1512 123.3%   
Imports (cif) Rs m2,4653,526 69.9%   
Fx inflow Rs m1552 29.4%   
Fx outflow Rs m2,677140 1,912.6%   
Net fx Rs m-2,662-88 3,013.7%   
CASH FLOW
From Operations Rs m9233,436 26.9%  
From Investments Rs m317-6,991 -4.5%  
From Financial Activity Rs m-481-619 77.7%  
Net Cashflow Rs m759-4,174 -18.2%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 51.1 63.9 80.0%  
Indian inst/Mut Fund % 11.3 7.5 150.7%  
FIIs % 7.2 4.9 146.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 23.7 128.3%  
Shareholders   21,978 85,207 25.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   TORRENT PHARMA  ALKEM LABORATORIES  DIVIS LABORATORIES  SANOFI INDIA  ALEMBIC PHARMA  

Compare WYETH LTD With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Of Pharma Drug Approvals, Global Updates, Oil Prices, and Top Stocks in Action Today(Pre-Open)

Indian share markets snapped their losing streak seen during last week and closed their Wednesday session on a positive note.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD - SUN PHARMA COMPARISON

COMPARE WYETH LTD WITH

MARKET STATS